Data from both the TCGA cohort and HCC patient samples confirmed that Nek2 is up-regulated in HCC samples, as compared to levels in non-tumor samples, and that higher expression is related to lower overall and recurrence-free survival. This evidence concerns the gene NEK2 and neoplasm.